logo
Plus   Neg
Share
Email

Recipharm Announces Terms Of Cash Offer For Consort Medical - Quick Facts

The boards of Recipharm AB, Recipharm Holdings Limited and Consort Medical plc have reached an agreement on the terms of a recommended cash offer to be made by Recipharm Holdings for the entire issued and to be issued share capital of Consort. Recipharm Holdings is a wholly-owned direct subsidiary of Recipharm AB.

Under the proposal, each Consort shareholder will be entitled to receive: for each Consort share 1,010 pence in cash. The proposed deal value the entire issued and to be issued ordinary share capital of Consort at approximately 505 million pounds on a fully diluted basis and implies an enterprise value of 627 million pounds.

The Consort Directors said they intend to recommend unanimously that Consort shareholders accept, or procure acceptance of, the offer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT